Sputter Deposition of Titanium on Poly(Methyl Methacrylate) Enhances Corneal Biocompatibility

Purpose To evaluate titanium (Ti) sputtering of the poly(methyl methacrylate) (PMMA) stem of the Boston Keratoprosthesis (BK) as a method to enhance interfacial adhesion between the PMMA and the recipient corneal tissue. Methods PMMA specimens were plasma treated with Ar/O2 and coated with Ti using a DC magnetron sputtering instrument. The topography and hydrophilicity of the surfaces were characterized using atomic force microscopy and a water contact angle instrument, respectively. Scratch hardness and adhesion of the Ti film were measured using a mechanical tester. Biocompatibility assessments were performed using cultured human corneal fibroblasts and whole blood ex vivo. The optical quality of the Ti sputtered BK was evaluated using a custom-made optical bench. Results By contact angle studies, the Ti coating improved PMMA hydrophilicity to match that of medical-grade Ti (Ti-6Al-4V-ELI). Ti sputtering of contact surfaces resulted in a plate-like morphology with increased surface roughness, without impacting the transparency of the BK optical component. Scratch testing indicated that the mechanical behavior of the Ti coating was similar to that of casted Ti, and the coating was stable in pull-off adhesion testing. Sputtered Ti film was highly biocompatible based on tests of cell viability, adhesion, proliferation, differentiation, collagen deposition, and keratocan expression, the properties of which exceeded those of uncoated PMMA and did not induce increased complement activation. Conclusions Titanium coating of the BK stem generated a mechanically and biologically favorable interface, which may help to enhance corneal stromal adhesion and biocompatibility. Translational Relevance Improving the biocompatibility of the BK PMMA stem may improve long-term outcomes of implantation.

[1]  J. Chodosh,et al.  Covalent Functionalization of PMMA Surface with L‐3,4‐Dihydroxyphenylalanine (L‐DOPA) to Enhance its Biocompatibility and Adhesion to Corneal Tissue , 2019, Advanced Materials Interfaces.

[2]  F. Albericio,et al.  Large-Area Biomolecule Nanopatterns on Diblock Copolymer Surfaces for Cell Adhesion Studies , 2019, Nanomaterials.

[3]  J. Chodosh,et al.  Lucia and Beyond: Development of an Affordable Keratoprosthesis , 2019, Cornea.

[4]  J. Chodosh,et al.  Finding an Optimal Corneal Xenograft Using Comparative Analysis of Corneal Matrix Proteins Across Species , 2019, Scientific Reports.

[5]  F. Delori,et al.  Improving the practicality and safety of artificial corneas: Pre-assembly and gamma-rays sterilization of the Boston Keratoprosthesis. , 2018, The ocular surface.

[6]  Jay C. Wang,et al.  Outcomes of Boston keratoprosthesis type 1 reimplantation: multicentre study results. , 2018, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[7]  L. Martinu,et al.  Review Article: Stress in thin films and coatings: Current status, challenges, and prospects , 2018 .

[8]  J. Mehta,et al.  Surface Modifications of the PMMA Optic of a Keratoprosthesis to Improve Biointegration. , 2017, Cornea.

[9]  Ali Khademhosseini,et al.  Spatially and Temporally Controlled Hydrogels for Tissue Engineering. , 2017, Materials science & engineering. R, Reports : a review journal.

[10]  R. Pankov,et al.  Live-cell biosensor for assessment of adhesion qualities of biomaterials. , 2017, Materials science & engineering. C, Materials for biological applications.

[11]  Bo Liedberg,et al.  Functionalization of the Polymeric Surface with Bioceramic Nanoparticles via a Novel, Nonthermal Dip Coating Method. , 2016, ACS applied materials & interfaces.

[12]  J. Chodosh,et al.  The Role of Titanium Surface Microtopography on Adhesion, Proliferation, Transformation, and Matrix Deposition of Corneal Cells. , 2016, Investigative ophthalmology & visual science.

[13]  K. J. Jeong,et al.  Titanium Coating of the Boston Keratoprosthesis , 2016, Translational vision science & technology.

[14]  M. Belin,et al.  Visual Acuity Outcomes of the Boston Keratoprosthesis Type 1: Multicenter Study Results. , 2016, American journal of ophthalmology.

[15]  S. van den Heuvel,et al.  Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression , 2016, Cell cycle.

[16]  K. Leong,et al.  Effect of surface treatment on adhesion strength between magnetron sputtered copper thin films and alumina substrate , 2015 .

[17]  J. Mehta,et al.  Surface Modification of PMMA to Improve Adhesion to Corneal Substitutes in a Synthetic Core-Skirt Keratoprosthesis. , 2015, ACS applied materials & interfaces.

[18]  Khalid Al Arfaj Boston keratoprosthesis – Clinical outcomes with wider geographic use and expanding indications – A systematic review , 2015, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[19]  Steven Busschots,et al.  Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines , 2014, MethodsX.

[20]  A. Cruzat,et al.  The Boston keratoprosthesis 2014: a step in the evolution of artificial corneas , 2014, Spektrum der Augenheilkunde.

[21]  Bo Nilsson,et al.  An international serum standard for application in assays to detect human complement activation products. , 2013, Molecular immunology.

[22]  J. Elisseeff,et al.  Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair. , 2013, Biomaterials.

[23]  I. Gipson,et al.  In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. , 2013, Investigative ophthalmology & visual science.

[24]  Michael W. Belin,et al.  Retention of the Boston keratoprosthesis type 1: multicenter study results. , 2013, Ophthalmology.

[25]  A. Djalilian,et al.  Outcomes of Boston Keratoprosthesis Implantation for Failed Keratoplasty After Keratolimbal Allograft , 2012, Cornea.

[26]  F. Yu,et al.  International results with the Boston type I keratoprosthesis. , 2012, Ophthalmology.

[27]  J. Enghild,et al.  Human Cornea Proteome: Identification and Quantitation of the Proteins of the Three Main Layers Including Epithelium, Stroma, and Endothelium , 2012, Journal of proteome research.

[28]  B. Spiller,et al.  The complement system: history, pathways, cascade and inhibitors. , 2012, European journal of microbiology & immunology.

[29]  S. Parapuram,et al.  Integrin β1 is necessary for the maintenance of corneal structural integrity. , 2011, Investigative ophthalmology & visual science.

[30]  K. J. Jeong,et al.  Hydroxyapatite for keratoprosthesis biointegration. , 2011, Investigative ophthalmology & visual science.

[31]  K. J. Jeong,et al.  Polydopamine coatings enhance biointegration of a model polymeric implant , 2011 .

[32]  Denis P. Dowling,et al.  Effect of Surface Wettability and Topography on the Adhesion of Osteosarcoma Cells on Plasma-modified Polystyrene , 2011, Journal of biomaterials applications.

[33]  Traian V Chirila,et al.  Human corneal endothelial cell growth on a silk fibroin membrane. , 2011, Biomaterials.

[34]  A. Ionescu,et al.  Generation of bioengineered corneas with decellularized xenografts and human keratocytes. , 2011, Investigative ophthalmology & visual science.

[35]  Douglas W DeSimone,et al.  The extracellular matrix in development and morphogenesis: a dynamic view. , 2010, Developmental biology.

[36]  H. Lee,et al.  Complement depletion with cobra venom factor delays acute cell‐mediated rejection in pig‐to‐mouse corneal xenotransplantation , 2010, Xenotransplantation.

[37]  M. Klufas,et al.  The Boston Keratoprosthesis , 2010, International ophthalmology clinics.

[38]  David C. Cameron,et al.  Adhesion of Ti and TiC Coatings on PMMA Subject to Plasma Treatment: Effect of Intermediate Layers of Al2O3 and TiO2 Deposited by Atomic Layer Deposition , 2009 .

[39]  I. Gipson,et al.  The Boston Keratoprosthesis: Comparing Corneal Epithelial Cell Compatibility with Titanium and PMMA , 2009, Cornea.

[40]  F. Yu,et al.  The Boston type I keratoprosthesis: improving outcomes and expanding indications. , 2009, Ophthalmology.

[41]  H. Zahouani,et al.  On the behaviour of obsidian under scratch test , 2009 .

[42]  K. Hammersmith The Boston Type I Keratoprosthesis: Improving Outcomes and Expanding Indications , 2009 .

[43]  Alyra J. Shaw,et al.  Eyelid pressure on the cornea , 2009 .

[44]  Jiucheng He,et al.  Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation. , 2008, Investigative ophthalmology & visual science.

[45]  Rony R. Sayegh,et al.  The Boston keratoprosthesis in Stevens-Johnson syndrome. , 2008, American journal of ophthalmology.

[46]  M. Harissi-Dagher,et al.  The Boston Keratoprosthesis in severe ocular trauma. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[47]  S. Kisin,et al.  Adhesion and adhesion changes at the copper metal–(acrylonitrile–butadiene–styrene) polymer interface , 2007 .

[48]  B. Hinz Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[49]  M. Stepp Corneal integrins and their functions. , 2006, Experimental eye research.

[50]  S. Tseng,et al.  Keratocan Expression of Murine Keratocytes Is Maintained on Amniotic Membrane by Down-regulating Transforming Growth Factor-β Signaling* , 2005, Journal of Biological Chemistry.

[51]  Frank P T Baaijens,et al.  Fibrin as a cell carrier in cardiovascular tissue engineering applications. , 2005, Biomaterials.

[52]  Arnaud Delcorte,et al.  Improvement of metal adhesion to silicone films : a ToF-SIMS study , 2004 .

[53]  S. Tseng,et al.  Human keratocytes cultured on amniotic membrane stroma preserve morphology and express keratocan. , 2003, Investigative ophthalmology & visual science.

[54]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[55]  P. Tresco,et al.  Relative importance of surface wettability and charged functional groups on NIH 3T3 fibroblast attachment, spreading, and cytoskeletal organization. , 1998, Journal of biomedical materials research.

[56]  T. Mollnes Complement and Biocompatibility , 1998, Vox sanguinis.

[57]  B. Nilsson,et al.  Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. , 1993, Biomaterials.

[58]  S. Frøland,et al.  Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex , 1985, Scandinavian journal of immunology.

[59]  B. Mondino,et al.  Distribution of hemolytic complement in the normal cornea. , 1981, Archives of ophthalmology.

[60]  J. Seyer,et al.  Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. , 1978, Proceedings of the National Academy of Sciences of the United States of America.